# OnCo record nectin-4-expression (biomarker). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/biomarkers/nectin-4-expression/>
  a schema:MedicalTest ;
  onco:kind "biomarker" ;
  schema:identifier "nectin-4-expression" ;
  schema:name "Nectin-4 expression"@en ;
  schema:alternateName "Nectin-4"@en, "NECTIN4 expression"@en, "Nectin-4 positive"@en, "Nectin-4 H-score"@en ;
  schema:description "Nectin-4 is expressed by almost every urothelial cancer, so enfortumab vedotin is given without a test. Nectin-4 amplification is being studied as a marker of especially strong response."@en ;
  schema:url <https://onco.cc/biomarkers/nectin-4-expression/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b5631d3e-4604-4363-8f20-11dfc5a4a8ed> ;
  onco:tag "biomarker", "surface-antigen", "no-threshold" ;
  onco:related <https://onco.cc/biomarkers/trop2-expression/>, <https://onco.cc/biomarkers/fgfr3-alteration/> ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:drugs <https://onco.cc/drugs/enfortumab-vedotin/> ;
  onco:terms <https://onco.cc/terms/ihc/>, <https://onco.cc/terms/gene-amplification/> .
